Bioregenx (BRGX) Cash & Equivalents (2021 - 2026)
Bioregenx's quarterly Cash & Equivalents came in at $45806.0 in Q1 2026, down 45.22% year-on-year from $83625.0 in Q1 2025, and down 33.98% quarter-over-quarter from $69383.0 in Q4 2025.
Bioregenx has reported Cash & Equivalents for 6 years, with the latest figure at $45806.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents fell 45.22% year-over-year to $45806.0; the trailing twelve-month figure through Mar 2026 stood at $45806.0 (down 45.22% YoY), and the FY2025 full-year result was $69383.0, up 18.8% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $45806.0, down from $69383.0 in the prior quarter.
- The five-year high for Cash & Equivalents was $125402.0 in Q4 2023, with the low at $676.0 in Q4 2022.
- Average Cash & Equivalents over 5 years is $48412.9, with a median of $46947.0 recorded in 2025.
- Year-over-year, Cash & Equivalents plunged 97.22% in 2022 and surged 18450.59% in 2023.
- Tracing BRGX's Cash & Equivalents over 5 years: stood at $676.0 in 2022, then surged by 18450.59% to $125402.0 in 2023, then tumbled by 53.43% to $58404.0 in 2024, then increased by 18.8% to $69383.0 in 2025, then sank by 33.98% to $45806.0 in 2026.
- The last three Cash & Equivalents figures came in at $45806.0 (Q1 2026), $69383.0 (Q4 2025), and $46947.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 1.42 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 888.80 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 265.37 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 186.67 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 219.18 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 34.34 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 490.29 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 419.52 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 174.90 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | 45,806.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45,806.00 |
| Dec 31, 2025 | 69,383.00 |
| Sep 30, 2025 | 46,947.00 |
| Jun 30, 2025 | 46,456.00 |
| Mar 31, 2025 | 83,625.00 |
| Dec 31, 2024 | 58,404.00 |
| Sep 30, 2024 | 70,081.00 |
| Jun 30, 2024 | 57,395.00 |
| Mar 31, 2024 | 114,158.00 |
| Dec 31, 2023 | 125,402.00 |
| Sep 30, 2023 | 758.00 |
| Dec 31, 2022 | 676.00 |
| Sep 30, 2022 | 1,541.00 |
| Jun 30, 2022 | 2,123.00 |
| Mar 31, 2022 | 3,438.00 |
| Dec 31, 2021 | 24,358.00 |